Fair Value Calculator Fair Value Calculator
EN DE

0191 (0191) Fair Value & Analysis

Industrials · Market cap HK$574M

0 0191 0191 · HK
PriceHK$0.6500
Fair ValueHK$0.5266
Upside-19.0%
Quality43/100
Evidence: Low Range HK$0.3929 – HK$0.5266

Fair value as of: Jul 1, 2026

From 7 valuation models · updated today

Share price −12.2% over the past month.

Price vs Fair Value (12 months)

HK$1.00 HK$0.4850 Fair Value HK$0.5266 Jun 2025 Jun 2026

12‑month range HK$0.4850 – HK$1.00 · fair‑value band HK$0.3929 – HK$0.5266 · the HK$0.6500 price screens above the HK$0.5266 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0191 (0191) currently trades at HK$0.6500, while our model-based Fair Value estimate is HK$0.5266 — implying the stock looks roughly 19.0% overvalued today. We read business quality at 43/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0191 generated revenue of HK$3.8B at a net margin of -59.4%. Revenue declined 4.2% year over year. It earns a return on equity of -13.5%. Net debt stands at HK$24.1B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$3.8B
Revenue growth (YoY) -4.2%
Net margin -59.4%
Return on equity -13.5%
Free cash flow HK$196M FY2025
Operating margin -6.7%
More key figures
EPS (TTM) HK$-3.52
Net debt HK$24.1B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0191 reported revenue of HK$5.0B in FY2025 versus HK$6.3B in FY2021, a compound −5.7%/yr. Reported net income was −HK$1.7B in FY2025.

Revenue −5.7%/yr
FY21 HK$6.3B
FY22 HK$5.4B
FY23 HK$5.3B
FY24 HK$6.1B
FY25 HK$5.0B
Net income
FY21 −HK$1.3B
FY22 −HK$1.2B
FY23 −HK$1.7B
FY24 −HK$2.2B
FY25 −HK$1.7B

Is 0191 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
Honeywell International Inc HON C$25.91 C$10.44 -60%
Hitachi, Ltd HTHIY $30.12 $23.57 -22%
CITIC Limited 0267 HK$12.87 HK$21.98 +71%
0019 0019 HK$81.70 HK$13.77 -83%
CK Hutchison Holdings 0001 HK$68.50 HK$52.56 -23%
Itaúsa S.A ITSA3 R$12.65 R$12.63 -0%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0191 (0191) undervalued?
As of Jul 1, 2026, our model estimates a fair value of HK$0.5266 versus a price of HK$0.6500 — about −19% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0191?
Our model-based fair value for 0191 is HK$0.5266 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.6500.
What is the quality score of 0191?
0191 has a Quality Score of 43/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0191 (0191)?
0191 reported trailing-twelve-month revenue of about HK$3.8B (latest available figure, as of Jul 1, 2026).
What is the net profit margin of 0191?
The net profit margin of 0191 is about -59.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.